Zynex (ZYXI) said late Wednesday that the temporary suspension of payments by Tricare will continue as its largest insurance customer conducts further review.
Zynex management appealed the suspension and presented its case in April to Tricare, the US Department of Defense's health care program administered through the Defense Health Agency.
The company's shares fell 5.6% in after-hours trading.